IMIC released its 2024 annual performance, with a net loss attributable to the parent company of 254 million yuan

According to the Zhitong Finance APP, International Medical (000516.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 4.815 billion yuan, a year-on-year increase of 4.28%. The net loss attributable to shareholders of the listed company was 254 million yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 287 million yuan, with a basic loss per share of 0.11 yuan